Language
English
German
^M
Dutch
Spanish
Title:
Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations
Source:
Human Genetics [0340-6717] yr:2012
Basic
Full text
Full text available via
SpringerLINK Contemporary 1997-Present
Year:
Volume:
Issue:
Start Page:
Document delivery
Request document via
Library/Bibliothek
Users interested in this article also expressed an interest in the following:
description
1.
Bolla, M.
"Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)."
The lancet
366.9485 (2005): 572-8.
description
2.
Hessvik, Nina P.
"Exosomal miRNAs as Biomarkers for Prostate Cancer."
Frontiers in genetics
4 (2013): 36-36.
description
3.
Jarzemski, W.
"The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland."
The Prostate
73.5 (2013): 542-548.
description
4.
Ewing, Charles M.
"Germline Mutations in HOXB13 and Prostate-Cancer Risk."
The New England journal of medicine
366.2 (2012): 141-149.
description
5.
Thompson, Ian M M.
"Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer: A Randomized Clinical Trial."
JAMA
296.19 (2006): 2329-2335.
description
6.
Van der Kwast, Theodorus H H.
"Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911."
Journal of clinical oncology
25.27 (2007): 4178-4186.
description
7.
Crawford, E David D.
"Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial."
The Journal of urology
181.3 (2009): 956-62.
description
8.
Wiegel, T.
"Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95."
Journal of clinical oncology
27.18 (2009): 2924-2930.
description
9.
Wiegel, T.
"Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96-02/AUO AP 09/95 Trial."
European urology
66.2 (2014): 243-50.
description
10.
Grisanzio, C.
"Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.(GENETICS)(Author abstract)(Report)."
Proceedings of the National Academy of Sciences of the United States of America
109.28 (2012): 11252-.
description
11.
Corcoran, C.
"Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes."
PLoS ONE
7.12 (2012): 1-.
description
12.
Martins, Vilma R.
"Tumor-cell-derived microvesicles as carriers of molecular information in cancer."
Current opinion in oncology
Publish Ahead of Print.1 (2012): 1-75.
description
13.
Knappskog, S.
"Re: Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis."
International journal of urology
19.10 (2012): 966-966.
description
14.
Xu, J.
"HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)."
Human genetics
132.1 (2012): 5-14.
description
15.
Thompson, I.
"Single and Multivariate Associations of MSR1, ELAC2, and RNASEL with Prostate Cancer in an Ethnic Diverse Cohort of Men."
Cancer epidemiology biomarkers & prevention
19.2 (2010): 588-599.
description
16.
Stewart, A M S.
"The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder."
Cell
99.6 (1999): 577-587.
description
17.
Dong, Jin-Tang T.
"Prevalent mutations in prostate cancer."
Journal of cellular biochemistry
97.3 (2006): 433-47.
description
18.
Bhaumik, S.
"Optical imaging of Renilla luciferase reporter gene expression in living mice."
Proceedings of the National Academy of Sciences of the United States of America
99.1 (2002): 377-382.
description
19.
Glantz, A..
"Intrahepatic cholestasis of pregnancy (ICP) - the relationsship between fetal complication rates and total serum bile acid levels."
American journal of obstetrics and gynecology
191.Supplement 1 (2004): 100-7.
description
20.
Olive, K.
"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome."
Cell
119.6 (2004): 847-60.
View More...
View Less...
Select All
Clear All
Save Citations
Select Format
RefWorks
EndNote
Reference Manager
ProCite
Submit citation export
Advanced
Author
Other articles by this author? -- in
GeoRef
Other articles by this author? -- in
Online Contents Geosciences
Other articles by this author? -- using
Web of Science
Web Search
Find related information in
a Web Search Engine
Excite
Google
HotBot
Ixquick
ZOO
Ask
Yahoo!
Bing
Naver
Search Terms:
Search for related information in
Google Scholar
Article Title
Journal Title
Other Search
Search Terms:
A service provided by the
Library of the Wissenschaftspark Albert Einstein
, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.